Malaria. Population at Risk. Infectious Disease epidemiology BMTRY 713 (Lecture 23) Epidemiology of Malaria. April 6, Selassie AW (DPHS) 1

Similar documents

Malaria. An Overview of Life-cycle, Morphology and Clinical Picture

ESCMID Online Lecture Library. by author

Invest in the future, defeat malaria

Malaria DR. AFNAN YOUNIS

Infectious Disease Epidemiology BMTRY 713 January 11, 2016 Lectures 2 Continuation of Introduction & Overview

Counting Malaria Out: Progress of Efforts in the Americas and More Stories of Innovations. Counting Malaria Out in the Americas

40% (90% (500 BC)

Epidemiology of Vector-Borne Diseases Laura C. Harrington, PhD

MALARIA CONTROL FROM THE INDIVIDUAL TO THE COMMUNITY

World Health Day Vector-borne Disease Fact Files

Lesson 1:Introduction To Malaria INTRODUCTION. Contents. Objectives. From WikiEducator

Parasitic Protozoa, Helminths, and Arthropod Vectors

INTERVENTION MODEL OF MALARIA

Alberta Health Public Health Notifiable Disease Management Guidelines July 2012

University of Veterinary and Animal Sciences, Bikaner), V.P.O. Bajor, Dist. Sikar, Rajasthan, India

Symptoms of Malaria. Young children, pregnant women, immunosuppressed and elderly travellers are particularly at risk of severe malaria.

The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Distribution of Plasmodium falciparum

5/11/2009. Information About Malaria. What is Malaria? How many people think Malaria is caused by mosquitoes? Evolution & History

Malaria Life Cycle Life Cycle

PARASITOLOGY CASE HISTORY #14 (BLOOD PARASITES) (Lynne S. Garcia)

Knowledge is power: 815 Second Avenue New York, NY Toll Free HEAL

Some Mathematical Models in Epidemiology

Cerebral malaria in children

Plasmodium Vivax Malaria Transmission in a Network of Villages

The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Watersheds of the African Continent

Malaria. Edwin J. Asturias, MD

Lyme disease Overview

Pacifica, Pilot Synod, 2011

Lyme disease Overview

Title: Author: Benji Mathews. Date: 1/4/08. Key words: Malaria, Travel, Medications

Protozoan Infections of the Circulatory System *

Transmission network dynamics of Plasmodium Vivax Malaria

Malaria and Global Warming. Jocelyn Maher & Mickey Rowe

Global Climate Change and Mosquito-Borne Diseases

Is Climate Change Affecting Vector-borne Disease Transmission?

A COMPARATIVE STUDY OF QUININE V/S ARTESUNATE IN SEVERE MALARIA PATIENTS IN NORTHWESTERN RAJASTHAN, INDIA

Malaria. by Dr. Ratnakar P. Kini

Journal Assignment #2. Malaria Epidemics throughout the World

Anti-Malaria Chemotherapy

malaria epidemics FD90C2A80F37419F A1B6C58 Malaria Epidemics 1 / 6

HUMASIS MALARIA ANTIGEN TEST HIGH SENSITIVE DIFFERENTIAL DIAGNOSIS OF MALARIA INFECTION

Malaria. benign (mild) malaria

Increase in temperatures in Africa, rise in humidity creating new water sources and the start of agriculture in the Middle East and North East Africa

Average Household Size and the Eradication of Malaria

Kato, N. et al, Nature, 2016, Accelerated Article Preview. Celeste Alverez Current Literature 9/10/ /10/2016 Celeste Wipf Group 1

AMREF DIRECTORATE OF LEARNING SYSTEMS MALARIA PREVENTION, CONTROL AND MANAGEMENT

Blood Smears Only 07 February Sample Preparation and Quality Control 12B A

L3-Malaria: Epidemiology, clinical management and control. 19 January 2018 SCBM346 TROPICAL INFECTIOUS DISEASES AND CONTROLS

Media centre Malaria. Key facts. Symptoms

Blood Smears Only 6 October Sample Preparation and Quality Control 15B-K

Malaria Risk Areas in Thailand Border

LESSON 3.2 WORKBOOK. Lesson 3.2: Reservoirs and vectors - Lyme disease and Malaria

The Alteration of Serum Glucose, Urea and Creatinine Level of Malaria Patients in Obowo Local Government Area of Imo State Nigeria

The Struggle with Infectious Disease. Lecture 5

Update on autochthonous Plasmodium vivax malaria in Greece

Context: Malaria, a disease spread by mosquitoes, kills more than two million people every year.

HEMOPOIETIC SYSTEM INFECTIONS BACTERIAL INFECTIONS OF THE BLOODSTREAM Reading Assignment: Chapters 50 & 63

INTRODUCTION PATIENTS, MATERIALS, AND METHODS

Malaria Entomology. Douglas E. Norris, PhD

AOHS Global Health. Unit 1, Lesson 3. Communicable Disease

Human Health Consequences of.

Fact sheet. Yellow fever

Blood and Lymphatic Infections Lecture 24 Dr. Gary Mumaugh

Blood Smears Only 5 February Sample Preparation and Quality Control 13B A

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable:

Disclosure Information

Malaria: Prevention remains our best measure for controlling the disease

How to design intranational deferral Malaria in Greece

Guidelines for the Treatment of Malaria

Malaria and Environment Hazards Spread Unchecked in the New Liberia FACTS FACTS FACTS

Case Study. Malaria and the human genome STUDENT S GUIDE. Steve Cross, Bronwyn Terrill and colleagues. Version 1.1

IDELINES FO R THE TREATMENT OF MALARIA. Second edition

MALARIA P. FALCIPARUM / P. VIVAX

Selassie AW (DPHS, MUSC) 1

UNDERSTANDING ZIKA AND MOSQUITO BORNE ILLNESSES

Looking Into Malaria. Parkland College. Ahmad Ahmad Parkland College. Recommended Citation

Running head: VECTOR-BORNE DISEASE 1

Disease Carrying Insects

THE MORTON COLLECTION:

CE Unit. Viruses and Vaccines

Unit 5: The Kingdoms of Life Module 12: Simple Organisms

Repellent Soap. The Jojoo Mosquito. Africa s innovative solution to Malaria prevention. Sapphire Trading Company Ltd

Study Plan: Screening

Cholera. Ebola. Symptoms of Ebola include. Fever. Severe headache. Muscle pain. Weakness. Fatigue. Diarrhea. Vomiting. Abdominal (stomach) pain

Ph.D. Thesis: Protective immune response in P.falciparum malaria 2011 CHAPTER I: Introduction. S.D. Lourembam 16

1,3,7 New Strategy for Malaria surveillance in elimination phases in China. Prof. Gao Qi

- Shahd Alqudah. - Moayyad Al-Shafei. - Malik Zihlif. 1 P a g e

Source: Dr. Volker Brinkmann, Max Planck Institute for Infection Biology, Berlin. [Picture in higher resolution]

Blood Smears Only 3 February Sample Preparation and Quality Control

Learning Objectives. 3. Epidemiology distribution; endemic; 4. Basic Morphology 5. Name of diesease 6. Prevention and Control

The Distribution of Human Differences. If all this genetic variation is so recent and continuous, why do we think of it in categorical terms?

Dengue Virus-Danger from Deadly Little Dragon

Infectious Disease epidemiology BMTRY 713 (Lecture 27) Review Slides for Final Exam. April 26, 2017 Department of Public Health Sciences

The Distribution of Human Differences. If all this genetic variation is so recent and continuous, why do we think of it in categorical terms?

Selassie AW (DPHS) 1

LESSON 3.2 WORKBOOK. Reservoirs and vectors Lyme diseases and Malaria

The Immune System: Your Defense Against Disease

Running Head: VECTOR-BORNE DISEASES: MALARIA IN CHILDREN 1

Kind of Annotation. Underline. Connecting. Highlighting. Boxing. Combination. Introduction: The Malaria Problem

Transcription:

Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 23 Vector-Borne Disease (Part II) Epidemiology of Malaria Learning Objectives 1. Overview of malaria Global perspectives 2. Identify clinical manifestations 3. Factors increasing transmission 4. Discuss Prevention strategies Malaria Malaria is an intermittent and remittent fever caused by a protozoan parasite that invades the red blood. The parasite is transmitted by mosquitoes in many tropical and subtropical regions. People with malaria often experience fever, chills, and flu-like illness. Left untreated, they may develop severe complications and die Population at Risk 3.4 billion people live in areas at risk of malaria transmission 106 countries at risk 207 million clinical episodes in 2012 110 million cases reported yearly 1-2 million cases are fatal 91% of the deaths are in Africa Selassie AW (DPHS) 1

Malaria Worldwide Africa South East Asia Central and South America Europe United States 94 million cases 5-10 million 1-2 million 500,000 1200 Agent of the disease Protozoan parasites of the genus Plasmodium 5 phases of the life cycle involving the mosquito vector and human host Affinity for erythrocytes varies with species P. falciparum is associated with most virulence and highest mortality in endemic African countries Selassie AW (DPHS) 2

The female Anopheles mosquito feeding on a human arm Anopheles gambiae Lifecycle of malarial parasite Trophozoites Schizont Hemoparasite P. falciparum Selassie AW (DPHS) 3

Hemoparasite P. falciparum Trophozoite stage Hemoparasite P. vivax Hemoparasite P. ovale Selassie AW (DPHS) 4

Hemoparasite P. malariae Asexual Life Cycle of Plasmodium Saliva of infected Anopheles enters host blood Sporozoites mature in the liver and attach to RBC receptor sites Lysis of the RBC releases mature sporozoites Clinical signs and symptoms are a result of this release of pyrogens Asexual division takes 48-72 hours Sexual Life Cycle of Plasmodium Gametocytes are released as RBC s are digested in the mosquito Gametocytes form zygotes which mature into sporozoites Migration of sporozoites to salivary glands of mosquito Selassie AW (DPHS) 5

Life Cycle of Plasmodium Extrinsic (sporogonic phase) takes 7-12 days Dependent on species and ambient temperature As temperature increases, length of developmental cycle decreases Anopheles Mosquito and Plasmodium Protozoan Mosquito Life Cycle Mate, store sperm, lay eggs 3-12 batches/life time Each batch requires blood meal from vertebrate Larvae hatch and feed at water s surface 5-15 days Pupal stage is 2-4 days Female adult must survive 7-12 days for the extrinsic cycle in order to transmit infection Transmission occurs with each blood meal Selassie AW (DPHS) 6

Vector Variables Host feeding preferences Digestion rates Frequency of blood meals Biting and resting habits Favored habitats for egg laying Predators/enemies Density of vectors related to humans Survival probability of vector during extrinsic incubation At Risk Host Infected-depends on parasite transmission and available prophylaxis for susceptibles Immune-depends on number of infected Susceptible-depends on number of immune Human Population Immunes Susceptibles Infected Immunity and Endemicity Climatic conditions that favor vector and parasite development contribute to a sustained infection rate among the population Seasonal climates allow loss of collective immunity Selassie AW (DPHS) 7

Host Response Intense and widespread immunological and cellular response Clinical response includes classic shaking chills, fever, sweats Childhood picture of P. falciparum include coma and convulsions, along with nonspecific stomach cramps, headache, cough, muscle aches Host Immunological Response Humoral Immunoglobulinemia Antibody dependent cellular inhibition Cellular Cytokine cascade defense Reticulocytosis Phagocytosis Protective Host Factors Nutritional deficiencies PABA, Mg., Pyridoxine, Riboflavin, Vit. C & E (Vitamin A supplementation helps combat disease) Protein Energy Malnutrition Iron deficiency anemia (value of treatment is greater than risk of intensifying disease) Sickle Cell Trait Selassie AW (DPHS) 8

Diagnosis ELISA/RIA Presence of antibodies lack clinical relevance in endemic areas PCR promising in drug trials Giemsa Stain Dependent on life cycle at parasite stage False positive in endemic areas Treatment/Prophylaxis Drugs Chloroquine (increasing resistance) Amodiaquine Chloproguanil and Dapsone (antifolates) Antimalarials protect against disease, not infection Experimental Treatment Artesunate suppositories for treatment en route to hospital when patient is too sick take med by mouth and IV access is not available Malaria vaccines Anti-sporozoite vaccines prevent infection Anti-sexual blood stage vaccines reduce severity Transmission-blocking vaccines reduce transmission Selassie AW (DPHS) 9

Environmental Influences Climate variables are distant in the web of causation Risk assessments are difficult to predict Temperature and Rainfall were the only factors considered in this analysis Climate Change Research Temperature Influences Mosquito longevity Frequency of blood meals Incubation period of the parasite Selassie AW (DPHS) 10

Mosquito Longevity and Survival Probability Optimal is 20º-25º (C) Threshold is 16º (C) Minimum is assumed to be 9º (C) 0.90 at 20º (C) 0.04 at 40º (C) 0.82 at 9º (C) Frequency of Blood Meals (Human Blood Index) Product of frequency and proportion of such meals from humans Depends on rate of digestion Digestion increases with ambient temperature Basic Reproduction Rate (R o ) Average number of secondary infections produced when one infected individual is introduced into a host population where everyone is susceptible Measure of an individual parasite s reproductive potential Selassie AW (DPHS) 11

Basic Reproduction Rate (R o ) R o <1: Disease will die out R o >1: Disease will spread indefinitely Allows calculation of critical density threshold of hosts necessary for parasite transmission Malaria Transmission Entomologic Inoculation Rate (EIR) Human host parameter based on landing rate and sporozoite rate Vectorial Capacity (VC) Vector parameter based on vector density, blood meals taken, survival probability, and extrinsic incubation Epidemic potential is reciprocal of vectors population s critical density Rainfall Influences Aquatic stage of mosquito Longevity of adult mosquito Selassie AW (DPHS) 12

Rainfall Criterion > 80 mm per month Minimum of 1.5 mm/day 50-60% relative humidity needed to survive relationship is poorly defined Critical Density of Hosts for Malaria Transmission N 1 2 N 2 L og( p) K 2 n N 1 a p N= Number of malaria mosquitoes per human (Critical Density) p = survival probability of mosquito a = frequency of taking human blood n = incubation period in vector K = constant incorporating variables independent of temp. Epidemic Potential is the reciprocal of the critical density 1 N 2 N1 Other Influences Rising populations Deforestation Health care access Drug resistant parasites Wars resulting in mass migration Agriculture, commerce causing migration of non-immune into endemic areas Water development projects Selassie AW (DPHS) 13